Table 3. Cox proportional hazards regression and logistic regression analysis of association of RC calculated from 2 serial PSAVs in 12 and 24-month windows from beginning of AS with biopsy reclassification during full patient followup or immediate next year in Johns Hopkins AS Program from 1995 to 2012.
Full Followup | Next Yr | |||
---|---|---|---|---|
|
|
|||
RC vs 0 | HR (95% CI)* | p Value | HR (95% CI)* | p Value |
12-Mo window (318 pts) | ||||
Any criteria: | ||||
1 | 1.32 (0.82–2.15) | 0.256 | 0.99 (0.42–2.34) | 0.982 |
2 | 1.27 (0.65–2.48) | 0.483 | 2.27 (0.85–6.06) | 0.101 |
Gleason score reclassification: | ||||
1 | 1.60 (0.77–3.32) | 0.209 | 0.48 (0.12–2.00) | 0.313 |
2 | 2.29 (0.85–6.14) | 0.101 | 2.09 (0.49–8.87) | 0.32 |
24-Mo window (168 pts) | ||||
Any criteria: | ||||
1 | 1.10 (0.55–2.18) | 0.792 | 1.30 (0.36–4.74) | 0.689 |
2 | 1.90 (0.61–5.90) | 0.266 | 4.99 (1.08–23.00) | 0.039 |
Gleason score reclassification: | ||||
1 | 0.42 (0.14–1.28) | 0.127 | 1.03 (0.13–8.04) | 0.975 |
2 | 1.22 (0.21–7.16) | 0.822 | 7.80 (0.54–113.25) | 0.132 |
Adjusted for age at diagnosis, race, PSAD at diagnosis, overall PSAV during followup and cancer on first surveillance biopsy.